Sudeep Pharma Limited – IPO
Sudeep Pharma Limited – IPO Details
| IPO Date | November 21, 2025 to November 25, 2025 |
| Listing Date | November 28, 2025 |
| Face Value | ₹ 1 / Share |
| Price Band | ₹ 563 to ₹ 593 / Share |
| Lot Size | 25 Shares |
| Total Issue Size | 1,50,92,750 shares (Aggregating up to ₹895.00 Cr) |
| Fresh Issue | 16,02,024 shares (Aggregating up to ₹95.00 Cr) |
| Offer for Sale | 1,34,90,726 shares of ₹1 (Aggregating up to ₹800.00 Cr) |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 11,13,46,602 shares |
| Share holding post issue | 11,29,48,626 shares |
| Market Maker portion |
Sudeep Pharma Limited Timeline (Tentative Schedule)
Sudeep Pharma Limited IPO opens on November 21, 2025, and closes on November 25, 2025.
| IPO Open Date | November 21, 2025 |
| IPO Close Date | November 25, 2025 |
| Basis of Allotment | November 26, 2025 |
| Initiation of Refunds | November 27, 2025 |
| Credit of Shares to Demat | November 27, 2025 |
| Listing Date | November 28, 2025 |
| Cut-off time for UPI mandate confirmation | November 25, 2025 |
Sudeep Pharma Limited IPO Lot Size
Investors can bid for a minimum of 25 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 25 | Rs.14,825 |
| Retail (Max) | 13 | 325 | Rs.192,725 |
| S-HNI (Min) | 14 | 350 | Rs.207,550 |
| S-HNI (Max) | 67 | 1,675 | Rs.993,275 |
| B-HNI (Min) | 68 | 1,700 | Rs.1,008,100 |
| HNI (Min) |
Sudeep Pharma Limited IPO Promoter Holding
| Share Holding Pre Issue | 89.37% |
| Share Holding Post Issue | 76.15% |
Sudeep Pharma Limited IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not more than 50% |
|
| NII (HNI) Shares Offered | Not less than 15% |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not less than 35.00% |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Sudeep Pharma Limited IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Sudeep Pharma Limited
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium
The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors
The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.
Product Portfolio:
- Pharmaceutical, Food and Nutrition Business
- Specialty Ingredients Business
- Triturates
As of December 31, 2024, the company had 704 permanent employees.
Competitve Strengths:
- Market leadership with a diversified product portfolio in a high barrier industry
- Distinguished global customer base with long-standing relationships with key customers
- Well-equipped and regulatory compliant Manufacturing Facilities
- Strong research and development capabilities
Key Performance Indicator
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | |
| ROCE | |
| Debt/Equity | 0.20 |
| RoNW | 27.88% |
| P/BV | 12.93 |
| PAT Margin (%) | 27.63% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 12.46 | 11.07 |
| P/E (x) | 47.61 | 53.55 |
Note:
- The Pre IPO EPS is calculated based on Pre-IPO shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2025, which is available in RHP.
Objects of the Issue (Sudeep Pharma Limited IPO Objectives)
Sudeep Pharma Limited Contact Details
Sudeep Pharma Ltd. 129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340 Phone: +91 265 284 0656 Email: [email protected] Website: https://www.sudeeppharma.com/ |
Sudeep Pharma Limited IPO Registrar
MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: [email protected] Website: https://linkintime.co.in/Initial_Offer/public-issues.html |